Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPAY
3151
DELISTED
FlexShopper
FPAY
| $253K | ﹤0.01% |
169,743
+36,136
| +27% | +$46.7K |
|
3152
Inuvo
INUV
$15.1M
| $253K | ﹤0.01% |
74,166
+46,326
| +166% | +$194K |
|
3153
Jerash Holdings
JRSH
$58.2M
| $253K | ﹤0.01% |
82,540
-400
| -0.5% | -$1.22K |
|
|
BNR
3154
Burning Rock Biotech
BNR
$93.9M
| $250K | ﹤0.01% |
34,270
-260
| -0.8% | -$2.17K |
|
|
CYBR
3155
DELISTED
CyberArk
CYBR
| $250K | ﹤0.01% |
+943
| New | +$234K |
|
3156
HBT Financial
HBT
$1.3B
| $249K | ﹤0.01% |
+13,100
| New | +$255K |
|
|
YARW
3157
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
| $247K | ﹤0.01% |
1,612
+684
| +74% | +$73.7K |
|
|
GURE
3158
Gulf Resources
GURE
$4.65M
| $246K | ﹤0.01% |
16,629
-1,020
| -6% | -$13.9K |
|
3159
Eton Pharmaceutcials
ETON
$1.27B
| $244K | ﹤0.01% |
65,031
+22,331
| +52% | +$97.5K |
|
3160
Luxfer Holdings
LXFR
$456M
| $244K | ﹤0.01% |
23,500
-185,707
| -89% | -$1.66M |
|
|
DDI
3161
DoubleDown Interactive
DDI
$574M
| $243K | ﹤0.01% |
22,300
+6,705
| +43% | +$73.4K |
|
3162
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$728M
| $241K | ﹤0.01% |
3,300
-2,400
| -42% | -$161K |
|
3163
MVB Financial
MVBF
$397M
| $241K | ﹤0.01% |
10,800
+500
| +5% | +$10.8K |
|
3164
PrimeEnergy Resources
PNRG
$298M
| $241K | ﹤0.01% |
2,400
| – | – |
|
|
AHG
3165
Akso Health Group
AHG
$1.35B
| $240K | ﹤0.01% |
206,798
+4,900
| +2% | +$6.75K |
|
3166
Alerus Financial
ALRS
$831M
| $240K | ﹤0.01% |
11,000
-2,800
| -20% | -$61.4K |
|
3167
Bank7 Corp
BSVN
$479M
| $240K | ﹤0.01% |
8,500
-683
| -7% | -$18.4K |
|
|
RSVR
3168
DELISTED
Reservoir Media
RSVR
| $239K | ﹤0.01% |
30,100
+17,252
| +134% | +$123K |
|
3169
SR Bancorp
SRBK
$142M
| $239K | ﹤0.01% |
25,300
-7,700
| -23% | -$72.8K |
|
|
DAY
3170
DELISTED
Dayforce
DAY
| $239K | ﹤0.01% |
3,600
-84,400
| -96% | -$5.76M |
|
|
AKYA
3171
DELISTED
Akoya BioSciences
AKYA
| $238K | ﹤0.01% |
50,700
+3,300
| +7% | +$17.1K |
|
|
PET
3172
DELISTED
Wag!
PET
| $237K | ﹤0.01% |
119,554
-8,632
| -7% | -$16.9K |
|
3173
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
| $236K | ﹤0.01% |
+2,900
| New | +$232K |
|
3174
The Beachbody Company
BODI
$70.6M
| $236K | ﹤0.01% |
24,564
+6,100
| +33% | +$57.8K |
|
3175
Humacyte
HUMA
$176M
| $235K | ﹤0.01% |
75,700
-19,400
| -20% | -$65.2K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.